Christine Djelalian is a dedicated Regulatory and Site Start-Up (RSU) Specialist 1 at IQVIA Canada, where she plays a pivotal role in the clinical trial process. With her extensive knowledge of Good Clinical Practice (GCP) and regulatory requirements, Christine serves as a Single Point of...
Christine Djelalian is a dedicated Regulatory and Site Start-Up (RSU) Specialist 1 at IQVIA Canada, where she plays a pivotal role in the clinical trial process. With her extensive knowledge of Good Clinical Practice (GCP) and regulatory requirements, Christine serves as a Single Point of Contact (SPOC) for investigative sites, ensuring seamless communication and collaboration throughout the study lifecycle. Her commitment to quality and adherence to standard operating procedures (SOPs) is evident in her meticulous approach to project management, where she oversees the feasibility and site identification phases, ensuring that all deliverables meet the highest standards.
In her current role, Christine is actively involved in key projects that require her expertise in regulatory submissions and site start-up activities. She excels at navigating the complexities of clinical trials, leveraging her skills in Electronic Data Capture (EDC) and Clinical Trial Management Systems (CTMS) to streamline processes and enhance operational efficiency. Her ability to adapt to changing circumstances and her strong interpersonal skills enable her to build effective relationships with stakeholders, from site personnel to project teams, fostering a collaborative environment that drives project success.
Christine's previous work experience has equipped her with a deep understanding of the pharmaceutical industry and the critical role that regulatory compliance plays in clinical research. Her passion for active listening and compassion allows her to address the needs of investigative sites effectively, ensuring that they feel supported and informed throughout the study process. As she continues to grow in her career, Christine remains committed to advancing her expertise in clinical operations and contributing to the success of innovative therapies that improve patient outcomes.
